Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What does today's news re:US patent mean?
- The company thinks that Anavex could be a medicine for High blood pressure?
- If so, does the company have to run a clinical trial for it?
This can be what you are looking for but this site doesn't allow me to put the Youtube link for it; search Youtube with the title:
Fragile X Spectrum and new Targeted Treatments for FXS and ASD
Thank you, Joseph.
They have been following Anavex for months if not years.
BioAroundWorld 2022 Sept Event - Knowledge Sharing uploaded on 9-20-2022
Anyone care to post the link to the webinar?
I saw the post by the 1st time poster but no webinar in it.
Thanks.
Congrats on your ownership of shares of AVXL. Did you erase the content in your 1st post? I see nothing in the post on the app. Like to know what it was about.
I share your sentiment 100% but I feel lucky when I see the performance of other bio stocks I invested in before, eg. ino, oncs, adxs, mrkr, bcli, etc
There’s a bright side for you:
You didn’t have to wait for 7 to 8 years watching paint being dried. : )
Hope you make a profit this year.
Not a good feeling as I agree with the all lines of your post.
I remember the year when you shared your meeting with Dr. M in person after ASM with this board if my memories serve right. I also remember that shareholders were not happy with him even back then. I hope we all win at the end.
Very well said no matter how good his opinions are re:A273.
A good pipe dream, sigh…….
If you connect those dots it’ll be a long line, very long. Lol
Very well spoken. Thanks.
Thank you for sharing. Dr. M seems to know more about A273 than we know.
Apparently, other DMTs are in phase 3 trials in the article are Donanemab (LY3002813) by Eli Lilly and Simufilam (PTI-125) by SAVA when I checked the given NTC number on clinicaltrials.gov.
Thank you for education on peer review.
I am with you 100% for Dr. M misled shareholders for that matter in 2019.
3 years passed already? I thought that was 2020.
I don't take company's timeline for milestones seriously any more since then.
He lied for it that year.
Cheers
Oh brada........sigh!
Are they Pluto and Mars?
Copied from his SOTC website (I copied for just 1H.):
My Timeline Projections for 2023
As the company approaches commercialization, there are a number of key milestones I am anticipating this year. These are my personal projections and trading should not be conducted based on these timelines.
Partnership: I expect this to be nearing completion, if not completed by May. Looking forward to a partner that can assist with manufacturing, promoting, and distributing Blarcamesine worldwide once approved for Alzheimer's specifically (which of course I expect based on this 2b/3 with potential for a phase 4).
Full AD Data: I expect this to be released by April and no later than June.
Parkinson's Disease Dementia OLE Data: I expect this to be released very close to or in conjunction with the full AD data, so in April to June. I have low confidence in this particular timeline however as I believe the data is probably available at this time, so release may be quite soon.
Things have to happen sooner or later, preferably Soooooner!
Joseph, I share your sentiment. It's my 8th year in Anavex.
This board was a lot warmer back in 2015~2018 supporting each member and sharing information. Yes, we had kund and his type even back then; frrol was a lot colder than now. I have witnessed that any group/society of people get divided and divided as times go by for many reasons. Anavex board is not an exception especially after CTAD in 2022 I think. We are in a tough time though things are ever more hopeful; does it make sense? Ha!
Childhood dementia- there’s a such thing?
It was no joke. hmmm
Thank you for fresh air from all these noise
Got it. Thanks.
"......... I believe I can make a substantial contribution at this very important time in the Company’s transition towards commercialization.”
Can I safely translate 'commercialization' to 'FDA or other regulatory agencies' approval'?
SP has been going down straight since 10:00 am today. Does that mean we had a good news announced?
I agree. One thing I don’t understand is why you stay here and ‘like’ all the negative messages re: Anavex all day long every day? Lol
I agree 100% and that’s how I feel about investor. He sounds like he wants Anavex rather fails.
Now ….. that’s the Georgejjl ll.
Yup that’s an old news. I gave up on scrolling down to find the date of the article on the website. Bummer
If you looooove & agreeeeee the way of presentation for Lecameneb, go right ahead and invest in it. lol
The COE of Anavex has different thoughts I guess and you defiantly don't agree with his.
Nothing wrong with your believing in that a P3 AD PM trial will be needed.
I have a problem with a investor when he/she repeats such a negative opinion on a stock message board. What is your purpose doing that other than FUD?
You and your posts sound like one who bets against AVXL.
A nice try though.
Thank you for the brief history of "Following A2-37". The latest chapter will be a minor and short one assuming Dr. M will explain it later. : )
Mayo, Thank you for sharing your knowledge, thoughts and enthusiasm in Anavex.
What did you do to be rewarded with an interview with a scientific advisor for a bio-company that you invest in? : ) (I don't expect your answer for it)
Thank you!
So childish. Hay, kido!
Wow, Do you even know if Anavex applied for an approval of the new AD drug in Australia, European Union and UK?
That would go first; I didn’t hear the news.
All stocks are RED, a crying baby!
My mistake to unignore you yesterday. lol
Thank you for sharing other's thoughts out there!
Remember a milestone that Dr. Missling kept on saying that Anavex would meet the milestone( forgot what it was now) by the end of 2021 and they didn't?
He knew and he was not honest I believed. Since then, I don't take Dr. M's time estimations seriously.
I respect for your careful controlling of investment money into a stock you have a belief. You have expressed it some time ago. You probably is the least greedy person in stock investing. I can't do that.
I'm all-in currently. If I lose it will not cause economic hardship for me neither but it will be a big loss and pain. I'm not a greedy person generally except in investing stocks. I don't know why. lol
GLTA
You probably meant $1249, not $1849 which doesn't really matter at this point.
But it's a half of Jesse's estimation which is unthinkable for me now anyways:
The article below was written by him before CTAD 2022 but he still seems to think a possibility of A273 available for patients this year.
If Alzheimer’s disease is approved in 2023, the company could see potential peak revenues of $17-24B annually (mid-valuation). With a P/E of 21.57 and minimal additional dilution, the share price would exceed $2,480 in the U.S. alone. Rett Syndrome peak sales alone could cause the share price to exceed $700 in similar circumstances.
@xxxxxx, Probably within the next 12 months.
https://www.sotcanalytics.com/home
Thank you ALL!